← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 31, 2016Last known activity
Jul 29, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (6)
- NCT06489093Lead sponsorEarly Phase 1Jul 29, 2024
- NCT05206539Lead sponsorPhase 3Sep 30, 2022
- NCT04733196Reponsible party - principal investigatorN/AOct 1, 2020
- NCT04733196Overall official - principal investigatorN/AOct 1, 2020
- NCT04733196Lead sponsorN/AOct 1, 2020
- NCT04702334CollaboratorN/AJan 31, 2016
Details
- Last known activity
- Jul 29, 2024